How does Refill confirm your pricing?

Four inputs generally shape the Refill rate you receive. First, SKU mix: semaglutide, tirzepatide, peptides, and hormones each carry different aggregate network costs across Refill's 503A partners. Second, platform tier, which sets your monthly subscription and transaction software fee percentage within the published roughly 1.5–5% range. Third, volume and meet-or-beat terms, since Refill advertises price matching against competing quotes. Fourth, ancillary economics: shipping, payment processing, Refill Connect fees, and optional provider encounters at about $30 hands-on or $50 hands-off per encounter. Because per-SKU medication rates are not on refill.co, written confirmation on your top lines matters more than a marketing headline about aggregate savings.

Treat onboarding pricing as something to verify, not assume. Ask for per-vial cost in writing on your top three SKUs, ask which tier sets your software fee, ask whether meet-or-beat rates hold across refill cycles, and ask what is included versus billed separately. A clear demo answer covers all four; a vague one leaves landed cost undefined until your first invoice.

Fizy Health inverts the timing problem for clinics with in-house prescribers. It shows resolved per-vial 503A cost on each catalog and cart line before checkout, with a separately disclosed facilitation fee at payment. That lets you run half of a pricing comparison immediately: read visible per-vial cost on semaglutide and tirzepatide, build a representative batch cart, and set that against whatever Refill confirms after demo.

Many clinics run that comparison on one refill week before choosing a primary workflow. The goal is not to skip Refill's process; it is to know what you are comparing against when aggregate rates and software fees finally land in writing.